Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 1270-1273, May 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lijinsky, W.
Right arrow Articles by Taylor, H. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lijinsky, W.
Right arrow Articles by Taylor, H. W.

Carcinogenicity of Methylated Dinitrosopiperazines in Rats1

William Lijinsky and H. Wayne Taylor

Carcinogenesis Program, Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830

Dinitrosopiperazine and four of its homologs were tested as carcinogens by feeding to rats at equimolar doses in drinking water. All 5 compounds induced tumors of the olfactory epithelium and/or esophagus in almost 100% of the animals, the tumors being the cause of death. The comparison of carcinogenic potency was based on the time to death of the animals after initiation of treatment by the different compounds.

One homolog, 2,5-dimethyldinitrosopiperazine, was approximately as potent as was dinitrosopiperazine. Dinitrosohomopiperazine, 2-methyldinitrosopiperazine, and 2,6-dimethyldinitrosopiperazine were considerably more effective carcinogens than was dinitrosopiperazine, a smaller dose killing the animals in a shorter time. The 2,6-dimethyl derivative was the most effective compound. The increased carcinogenicity of the homologs might be related to steric effects or to activation at the {alpha} carbon atoms to the N-nitroso group.

1 Research jointly supported by the Carcinogenesis Program of the National Cancer Institute and by the U. S. Atomic Energy Commission under contract with the Union Carbide Corporation.

Received 12/ 9/74. Accepted 2/ 6/75.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.